|WuXi PharmaTech (Cayman) Inc., (WuXi) is a pharmaceutical, biotechnology and medical device research and development (R&D) outsourcing company, with operations in People's Republic of China and the United States. The Company provides a portfolio of laboratory and manufacturing services throughout the R&D process to its customers, which include the world's pharmaceutical, biotechnology and medical device companies. The Company has added some services, including discovery biology, safety pharmacology, drug metabolism and pharmacokinetics (DMPK), bioanalytical services, manufacturing process R&D, clinical-trial-scale manufacturing, formulation, toxicology and commercial-scale manufacturing. The Company operates in two segments: Laboratory services segment and Manufacturing Services Segment. In October 2011, the Company acquired Abgent, Inc. In October 2011, the Company acquired MedKey Med-Tech Development Co. Ltd. and Jiecheng Med-Tech Development Co. Ltd.